ECC 2013 Immuno-Oncology Satellite Symposium supported by Bristol-Myers Squibb. Immuno-Oncology: the next new paradigm in cancer treatment?

Prof. Gerritsen sets the scene for the symposium, emphasizing the potential and enthusiasm for immuno-oncology as a new modality for cancer therapy.

To view the slides fullscreen click the square and arrows button at the bottom right of the player.